Mylan Insulin Aspart Study

NCT03760068 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

478

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: MYL-1601D Product
DRUG: FlexPen NovoLog®

Sponsor

Mylan Inc.

Collaborators

[object Object]